Schatzman Randall C 4
4 · Bolt Biotherapeutics, Inc. · Filed Feb 23, 2022
Insider Transaction Report
Form 4
Schatzman Randall C
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-18+630,000→ 630,000 totalExercise: $3.08Exp: 2032-02-17→ Common Stock (630,000 underlying)
Footnotes (1)
- [F1]For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2022.